Afatinib
Indications: - Other specified malignant neoplasms of bronchus or lung Source: EML workbook import
MOQ: 1
Kes0.00
Product image unavailable
Ibrutinib
Vendor: Marketplace supplier
Formulations:
- Oral > Solid: 140 mg
Indications:
- Chronic lymphocytic leukaemia or small lymphocytic lymphoma
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Kes0.00
Availability
Supplier and price will be confirmed during RFQ.
Formulations:
- Oral > Solid: 140 mg
Indications:
- Chronic lymphocytic leukaemia or small lymphocytic lymphoma
Source: EML workbook import
Similar Products
All-Trans Retinoic Acid
Formulations: - Oral > Solid: 10 mg capsule Indications: - Acute myeloid leukaemia with recurrent genetic abnormalities Source: EML workbook import
MOQ: 1
Kes0.00
Bortezomib
Formulations: - Parenteral > General injections > unspecified: 3.5 mg in vial powder for injection Indications: - Plasma cell myeloma Source: EML workbook import
MOQ: 1
Kes0.00
Dasatinib
Formulations: - Oral > Solid: 20 mg tablet; 50 mg tablet; 70 mg tablet; 80 mg tablet; 100 mg tablet; 140 mg tablet Indications: - Chronic myeloid leukaemia, not elsewhere classified Source: EML workbook import
MOQ: 1
Kes0.00
Erlotinib
Formulations: - Oral > Solid: 100 mg; 150 mg Indications: - Other specified malignant neoplasms of bronchus or lung Source: EML workbook import
MOQ: 1
Kes0.00
Everolimus
Formulations: - Oral > Solid > dispersible tablet: 2 mg; 3 mg; 5 mg Oral > Solid > tablet: 2.5 mg; 5 mg; 7.5 mg; 10 mg Indications: - Other specified gliomas of brain Source: EML workbook import
MOQ: 1
Kes0.00
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.